SMALL CELL LUNG-CANCER - SINGLE AGENTS REVISITED

被引：1
作者：
CLARK, PI
SLEVIN, ML
机构：
[1] HOMERTON HOSP,LONDON EC1A 7BE,ENGLAND
[2] ST BARTHOLOMEWS HOSP,IMPERIAL CANC RES FUND,DEPT MED ONCOL,LONDON EC1A 7BE,ENGLAND
来源：
RESPIRATORY MEDICINE | 1989年 / 83卷 / 05期
关键词：
D O I：
10.1016/S0954-6111(89)80068-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：381 / 382
页数：2
相关论文
共 13 条
[1]  
AISNER J, 1983, CANCER TREAT REP, V67, P37
[2]   TENIPOSIDE (VM-26), AN OVERLOOKED HIGHLY-ACTIVE AGENT IN SMALL-CELL LUNG-CANCER - RESULTS OF A PHASE-II TRIAL IN UNTREATED PATIENTS [J].
BORK, E ;
HANSEN, M ;
DOMBERNOWSKY, P ;
HANSEN, SW ;
PEDERSEN, AG ;
HANSEN, HH .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (04) :524-527
[3]  
CLARK P, 1988, LUNG CANCER, V4, P108
[4]  
EAGAN RT, 1976, CANCER TREAT REP, V60, P949
[5]  
EDMONSON JH, 1976, CANCER TREAT REP, V60, P925
[6]  
LOWENBRAUN S, 1979, CANCER, V44, P406, DOI 10.1002/1097-0142(197908)44:2<406::AID-CNCR2820440206>3.0.CO
[7]  
2-1
[8]  
MACAULAY V, 1986, RANDOMISED TRIALS CA
[9]  
MAURER LH, 1980, CANCER, V45, P30, DOI 10.1002/1097-0142(19800101)45:1<30::AID-CNCR2820450107>3.0.CO
[10]  
2-6
12